Reducing Transphobia Among Adolescents Through a Brief Video Intervention
NCT ID: NCT04969003
Last Updated: 2022-05-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
200 participants
INTERVENTIONAL
2022-03-01
2022-04-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
1. reduce transphobia;
2. reduce depression-related stigma and increase likelihood of treatment-seeking; and
3. examine the role of viewer's sex (male / female / non-binary), race (Black vs non-Black), and sexual orientation (straight vs LGBQ) as independent factors on the outcomes of interest.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Transgender Health: an Educational RCT
NCT05080335
Trans Care: An Online Intervention to Reduce Symptoms of Gender Dysphoria
NCT05903911
Psychological Vulnerabilities and Transgender Adolescents: A Descriptive Epidemiology Study
NCT05126134
Minority Joy and Minority Stress in Trans People: an Intervention Study
NCT05693324
Feasibility and Acceptability of Mindful Self-Compassion Among Transgender and Nonbinary Young Adults
NCT06409975
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Assessments will occur at baseline and post-intervention, and will include:
1. Demographics (baseline only);
2. Primary outcome:
a. Attitudes toward Transgender Men and Women (ATTMW) scale.
3. Secondary outcome:
1. Transgender attitudes: feelings thermometer, modeled after Norton et al 2013.
2. Depression-related stigma (Depression Stigma Scale \[DSS\]);and
3. Help-seeking (General Help-Seeking Questionnaire \[GHSQ\]).
For each of study we intend to randomly assign \~1,000 individuals aged 14-18 as follows:
Randomized, in equal proportions, and stratified by sex and race, to view one of four \~100-second videos:
1. Transgender male;
2. Cis-gender male);
3. Transgender female;
4. Cis-gender female.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Transgender male (TM)
\~90-second video of depressed transgender male
Short videos
Intervention videos will each be of 90-second duration and feature four underage professionals (ages 16) acting as simulated patients. All videos will focus on an empowered presenter with depression sharing their personal story regarding depression and describe how social supports from family, friends, and community, as well as professional help assisted them in overcoming symptoms of their illness. The actors will include a transgender male, a cis-gender male, a transgender female, and a cis-gender female.
Cis-gender male (CM)
\~90-second video of depressed cis-gender male
Short videos
Intervention videos will each be of 90-second duration and feature four underage professionals (ages 16) acting as simulated patients. All videos will focus on an empowered presenter with depression sharing their personal story regarding depression and describe how social supports from family, friends, and community, as well as professional help assisted them in overcoming symptoms of their illness. The actors will include a transgender male, a cis-gender male, a transgender female, and a cis-gender female.
Transgender female (TF)
\~90-second video of depressed transgender female
Short videos
Intervention videos will each be of 90-second duration and feature four underage professionals (ages 16) acting as simulated patients. All videos will focus on an empowered presenter with depression sharing their personal story regarding depression and describe how social supports from family, friends, and community, as well as professional help assisted them in overcoming symptoms of their illness. The actors will include a transgender male, a cis-gender male, a transgender female, and a cis-gender female.
Cis-gender female (CF)
\~90-second video of depressed cis-gender female
Short videos
Intervention videos will each be of 90-second duration and feature four underage professionals (ages 16) acting as simulated patients. All videos will focus on an empowered presenter with depression sharing their personal story regarding depression and describe how social supports from family, friends, and community, as well as professional help assisted them in overcoming symptoms of their illness. The actors will include a transgender male, a cis-gender male, a transgender female, and a cis-gender female.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Short videos
Intervention videos will each be of 90-second duration and feature four underage professionals (ages 16) acting as simulated patients. All videos will focus on an empowered presenter with depression sharing their personal story regarding depression and describe how social supports from family, friends, and community, as well as professional help assisted them in overcoming symptoms of their illness. The actors will include a transgender male, a cis-gender male, a transgender female, and a cis-gender female.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Living in the US
* Ages 14 - 18
Exclusion Criteria
14 Years
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Yale University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Yale Child Center
New Haven, Connecticut, United States
Yale Child Study Center
New Haven, Connecticut, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Griffiths KM, Christensen H, Jorm AF, Evans K, Groves C. Effect of web-based depression literacy and cognitive-behavioural therapy interventions on stigmatising attitudes to depression: randomised controlled trial. Br J Psychiatry. 2004 Oct;185:342-9. doi: 10.1192/bjp.185.4.342.
Wilson CJ, Deane FP, Marshall KL, Dalley A. Adolescents' suicidal thinking and reluctance to consult general medical practitioners. J Youth Adolesc. 2010 Apr;39(4):343-56. doi: 10.1007/s10964-009-9436-6. Epub 2009 Jul 15.
Norton AT, Herek GM. Heterosexuals' attitudes toward transgender people: findings from a national probability sample of US Adults. Sex Roles. 2013;68(11-12):738-753. doi:10.1007/s11199-011-0110-6
Billard TJ. Attitudes Toward Transgender Men and Women: Development and Validation of a New Measure. Front Psychol. 2018 Apr 3;9:387. doi: 10.3389/fpsyg.2018.00387. eCollection 2018.
Amsalem D, Halloran J, Penque B, Celentano J, Martin A. Effect of a Brief Social Contact Video on Transphobia and Depression-Related Stigma Among Adolescents: A Randomized Clinical Trial. JAMA Netw Open. 2022 Feb 1;5(2):e220376. doi: 10.1001/jamanetworkopen.2022.0376.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2000028980_a
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.